van der Poel HG - Search Results

1

A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promoters.

van der Poel HG, McCadden J, Verhaegh GW, Kruszewski M, Ferrer F, Schalken JA, Carducci M, Rodriguez R. van der Poel HG, et al. Cancer Gene Ther. 2001 Dec;8(12):927-35. doi: 10.1038/sj.cgt.7700385. Cancer Gene Ther. 2001. PMID: 11781655

2

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG, Simons JW. DeWeese TL, et al. Cancer Res. 2001 Oct 15;61(20):7464-72. Cancer Res. 2001. PMID: 11606381 Clinical Trial.

3

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.

Tamimi Y, van der Poel HG, Karthaus HF, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: van der poel hg. Br J Cancer. 1996 Aug;74(4):573-8. doi: 10.1038/bjc.1996.403. Br J Cancer. 1996. PMID: 8761372 Free PMC article.

4

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

5

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

6

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

Tamimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HF, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: van der poel hg. Cancer Res. 1993 Nov 15;53(22):5512-6. Cancer Res. 1993. PMID: 8221692

7

Automated image analysis for bladder cancer.

van der Poel HG, Witjes JA, Schalken JA, Debruyne FM. van der Poel HG, et al. Urol Res. 1998;26(1):1-5. doi: 10.1007/s002400050014. Urol Res. 1998. PMID: 9537688 Review.

8

Quantitative light microscopy in urological oncology.

van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FM, Schalken JA. van der Poel HG, et al. J Urol. 1992 Jul;148(1):1-13. doi: 10.1016/s0022-5347(17)36494-7. J Urol. 1992. PMID: 1613843 Review. No abstract available.

9

Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

van der Poel HG, Mulders PF, Aalders TW, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Anal Cell Pathol. 1994 Aug;7(2):153-70. Anal Cell Pathol. 1994. PMID: 7993825

10

Image analysis in superficial transitional cell carcinoma of the bladder.

van der Poel HG, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Semin Urol. 1993 Aug;11(3):164-70. Semin Urol. 1993. PMID: 8210837 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page